Skip to main content
. 2008 Jan 23;2008(1):CD006395. doi: 10.1002/14651858.CD006395.pub2

Mathews 1967.

Methods Performance bias: blinding of participants ‐ yes; blinding of caregiver ‐ yes; blinding of outcome assessment ‐ yes. 
 Attrition bias: 15.6% of participants discontinued medication. 
 Completeness of follow up: yes.
Participants Country: UK. 
 Number: 31 women in the intervention group, 33 women in the control group. 
 Gestational age at trial entry: between 28 and 32 weeks.
Interventions Isoxsuprine 30 mg 4 times a day versus placebo.
Outcomes Incidence of: 
 ‐ birth less than 36 weeks; 
 ‐ neonatal mortality; 
 ‐ birthweight less than 2500 grams. 
 Mean gestational age. 
 Mean birthweight.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear